Nolvadex D 20mg Tablet 30's contains Tamoxifen Citrate 20mg as its active ingredient. Tamoxifen Citrate is a selective estrogen receptor modulator (SERM) used primarily in the treatment of estrogen receptor-positive breast cancer in both men and women. It works by binding to estrogen receptors in breast tissues, thereby blocking the effects of estrogen, which is necessary for the growth of certain types of breast cancer cells. Nolvadex D is also used to reduce the risk of breast cancer recurrence and for prevention in high-risk individuals. Side Effects Common side effects of Nolvadex D 20mg Tablet 30's may include: Hot flashes Nausea or vomiting Vaginal discharge or bleeding Fatigue Mood changes or depression Breast tenderness or swelling Rare but serious side effects may include: Blood clots Stroke Risk of uterine cancer in postmenopausal women Vision changes or development of cataracts If you experience any severe or unusual symptoms, consult your healthcare provider immediately. Precautions Before taking Nolvadex D 20mg Tablet 30's, consider the following precautions: Do not use if you have a known allergy to Tamoxifen Citrate or any of its components. Not recommended during pregnancy or breastfeeding due to potential risks to the fetus or infant. Monitor for the signs of blood clots, stroke, or changes in vision while on treatment. Use with caution in patients with liver disease or a history of blood clotting disorders. Inform your healthcare provider about other medications you are taking to avoid drug interactions.

Uses Nolvadex D 20mg Tablet 30's is indicated for: Treatment of estrogen receptor-positive breast cancer in both premenopausal and postmenopausal women. Prevention of breast cancer in high-risk individuals. Reducing the risk of breast cancer recurrence in patients with a history of breast cancer. Benefits Effective in slowing or halting the growth of estrogen-dependent breast cancer cells. Reduces the risk of recurrence of breast cancer. Can be used as a preventive measure for individuals at high risk for breast cancer.

The recommended dose is 20mg once daily, as directed by your healthcare provider. Treatment duration may depend on the patient's condition and response to therapy. Regular monitoring is necessary during treatment to assess for adverse effects or changes in symptoms.